Humana Inc's Revenue in the fiscal year 2025 $ 129,664.00 millions
Humana Inc's Revenue in the fiscal year 2024 $ 117,761.00 millions
Humana Inc's Revenue in the fiscal year 2023 $ 106,374.00 millions
Humana Inc's Revenue in the fiscal year 2022 $ 92,870.00 millions
Humana Inc's Revenue in the fiscal year 2021 $ 83,064.00 millions
HUM Revenue third quarter 2026 Y/Y Growth Comment
Humana Inc achieved in the third quarter 2026, above Company average Revenue growth of 26.05% year on year, to $ 41,155.00 millions.
Looking into third quarter 2026 results within Accident & Health Insurance industry 3 other companies have achieved higher Revenue growth. While Humana Inc' s Revenue rise of 26.05% ranks overall at the positon no. 858 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Humana Inc's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
28.43 %
3.05 %
-7.44 %
(March 31, 2006)
HUM's III. Quarter Q/Q Revenue Comment
Humana Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.7% quarter on quarter, to $ 41,155.00 millions.
Within Accident & Health Insurance industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Humana Inc's Revenue growth quarter on quarter, overall rank is 1701.
Humana Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.7% quarter on quarter, to $ 41,155.00 millions.
Within Accident & Health Insurance industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Humana Inc's Revenue growth quarter on quarter, overall rank is 1701.
Humana Inc's 12 Months Revenue Growth Year on Year
Humana Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 22.02% year on year, to $ 154,185 millions if the fiscal year would have ended in Sep 30 2026. Humana Inc's trailing twelve months Revenue growth was higher than company's average 12.15% and higher than 18.33% growth in Jun 30 2026. But from twelve months ended Jun 30 2026 rise was beneth at 5.84 % from $145679 millions achieved in the period from Jun 30 2026 to Sep 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at12.15%.
In the Financial sector 393 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1192, from total ranking in previous quarter at 1706.
Humana Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 22.02% year on year, to $ 154,185 millions if the fiscal year would have ended in Sep 30 2026. Humana Inc's trailing twelve months Revenue growth was higher than company's average 12.15% and higher than 18.33% growth in Jun 30 2026. But from twelve months ended Jun 30 2026 rise was beneth at 5.84 % from $145679 millions achieved in the period from Jun 30 2026 to Sep 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at12.15%. The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 5.84 % increase from $145679 millions in the period from Jun 30 2026 to Sep 30 2025.
In the Financial sector 393 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1192, from total ranking in previous quarter at 1706.
About Humana Inc Revenue Growth Rates (HUM), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.